Morihiro Watanabe

805 total citations
33 papers, 669 citations indexed

About

Morihiro Watanabe is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Morihiro Watanabe has authored 33 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 8 papers in Surgery. Recurrent topics in Morihiro Watanabe's work include Immunotherapy and Immune Responses (6 papers), Hormonal Regulation and Hypertension (6 papers) and Immune Cell Function and Interaction (5 papers). Morihiro Watanabe is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Hormonal Regulation and Hypertension (6 papers) and Immune Cell Function and Interaction (5 papers). Morihiro Watanabe collaborates with scholars based in Japan, Germany and United States. Morihiro Watanabe's co-authors include Teruhiro Nakada, Yōko Kubota, Manabu Ishigooka, Isoji Sasagawa, Takashi Yagisawa, Toshihiko Doi, Munehisa Takahashi, Mutsuo Furihata, Tomoko Okada and Robert H. Wiltrout and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Morihiro Watanabe

33 papers receiving 657 citations

Peers

Morihiro Watanabe

ONCOL

IMMUN

SURGE

MB

PRM

Laurentiu M. Pop United States

Hideo Goto Japan

Cheng‐Lung Hsu Taiwan

Yi‐Ting Yen Taiwan

Erhard Seifried Germany

Glauce Aparecida Pinto Brazil

Olli Helminen Finland

Eliana Gulotta Italy

Yuji Nakafusa Japan

Christopher J. Groves United Kingdom

Laurentiu M. Pop United States

Morihiro Watanabe

318 ×1.4

ONCOL

376 ×1.8

IMMUN

90 ×0.5

SURGE

297 ×1.9

MB

170 ×1.5

PRM

Citations per year, relative to Morihiro Watanabe Morihiro Watanabe (= 1×) peers Laurentiu M. Pop

Countries citing papers authored by Morihiro Watanabe

Since Specialization

Citations

This map shows the geographic impact of Morihiro Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morihiro Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morihiro Watanabe more than expected).

Fields of papers citing papers by Morihiro Watanabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morihiro Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morihiro Watanabe. The network helps show where Morihiro Watanabe may publish in the future.

Co-authorship network of co-authors of Morihiro Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Morihiro Watanabe. A scholar is included among the top collaborators of Morihiro Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morihiro Watanabe. Morihiro Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Shitara, Kohei, Kentaro Yamazaki, Takahiro Tsushima, et al.. (2020). Phase I trial of the MET inhibitor tepotinib in Japanese patients with solid tumors. Japanese Journal of Clinical Oncology. 50(8). 859–866. 25 indexed citations

2.

Doi, Toshihiko, Satoru Iwasa, Kei Muro, et al.. (2018). Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the JAVELIN Solid Tumor JPN trial. Gastric Cancer. 22(4). 817–827. 49 indexed citations

3.

Kojima, Takashi, Kentaro Yamazaki, Ken Kato, et al.. (2018). Phase I dose‐escalation trial of Sym004, an anti‐EGFR antibody mixture, in Japanese patients with advanced solid tumors. Cancer Science. 109(10). 3253–3262. 15 indexed citations

4.

Katakami, Nobuyuki, Toyoaki Hida, Hiroshi Nokihara, et al.. (2017). Phase I/II study of tecemotide as immunotherapy in Japanese patients with unresectable stage III non-small cell lung cancer. Lung Cancer. 105. 23–30. 26 indexed citations

5.

Maruyama, Kouji, Zohair Selmani, Hidee Ishii, et al.. (2012). Flt3 ligand enhances anti-tumor effects of antibody therapeutics. International Immunopharmacology. 12(3). 481–486. 1 indexed citations

6.

Rodriguez‐Galán, María Cecilia, Della Reynolds, Silvia G. Correa, et al.. (2009). Coexpression of IL-18 Strongly Attenuates IL-12-Induced Systemic Toxicity through a Rapid Induction of IL-10 without Affecting its Antitumor Capacity. The Journal of Immunology. 183(1). 740–748. 25 indexed citations

7.

Takahashi, Munehisa, et al.. (2009). Chemokine CCL2/MCP-1 negatively regulates metastasis in a highly bone marrow-metastatic mouse breast cancer model. Clinical & Experimental Metastasis. 26(7). 817–828. 53 indexed citations

8.

Takahashi, Munehisa, Mutsuo Furihata, Nobuyoshi Akimitsu, et al.. (2008). A highly bone marrow metastatic murine breast cancer model established through in vivo selection exhibits enhanced anchorage-independent growth and cell migration mediated by ICAM-1. Clinical & Experimental Metastasis. 25(5). 517–529. 40 indexed citations

9.

Ohta, Shoichiro, Edwin W. Lai, John C. Morris, et al.. (2007). Metastasis‐associated gene expression profile of liver and subcutaneous lesions derived from mouse pheochromocytoma cells. Molecular Carcinogenesis. 47(4). 245–251. 15 indexed citations

10.

Ortaldo, John R., Robin Winkler-Pickett, Earl W. Bere, et al.. (2005). In Vivo Hydrodynamic Delivery of cDNA Encoding IL-2: Rapid, Sustained Redistribution, Activation of Mouse NK Cells, and Therapeutic Potential in the Absence of NKT Cells. The Journal of Immunology. 175(2). 693–699. 26 indexed citations

11.

Watanabe, Morihiro, Robert G. Fenton, Jon M. Wigginton, et al.. (1999). Intradermal Delivery of IL-12 Naked DNA Induces Systemic NK Cell Activation and Th1 Response In Vivo That Is Independent of Endogenous IL-12 Production. The Journal of Immunology. 163(4). 1943–1950. 36 indexed citations

12.

Fogler, William E., K Völker, Morihiro Watanabe, et al.. (1998). Recruitment of Hepatic NK Cells by IL-12 Is Dependent on IFN-γ and VCAM-1 and Is Rapidly Down-Regulated by a Mechanism Involving T Cells and Expression of Fas. The Journal of Immunology. 161(11). 6014–6021. 37 indexed citations

13.

Kubota, Y., Teruhiro Nakada, Hiroshi Yanai, et al.. (1996). Electropermeabilization in bladder cancer chemotherapy. Cancer Chemotherapy and Pharmacology. 39(1-2). 67–70. 19 indexed citations

14.

Nakada, Teruhiro, Yoshiaki Iijima, Yōko Kubota, et al.. (1996). Increased Vascular Collagen and Noncollagenous Protein Synthesis Contributes to Sustain Chronic Phase of Two-Kidney, One-Clip Renovascular Hypertension. The Journal of Urology. 156(3). 1180–1185. 6 indexed citations

15.

Nakada, Teruhiro, Yōko Kubota, Hitoshi Suzuki, et al.. (1996). Suppression of Sympathetic Nervous System Attenuates the Development of Two-Kidney, One-Clip Goldblatt Hypertension. The Journal of Urology. 156(4). 1480–1484. 15 indexed citations

16.

Nakada, Teruhiro, Yoshiaki Iijima, Yōko Kubota, et al.. (1996). Increased Vascular Collagen and Noncollagenous Protein Synthesis Contributes to Sustain Chronic Phase of Two-Kidney, One-Clip Renovascular Hypertension. The Journal of Urology. 1180–1185. 2 indexed citations

17.

Nakada, Teruhiro, Yōko Kubota, Isoji Sasagawa, et al.. (1995). Removal of Large Adrenal Tumor on the Right Side with Liver Mobilization. Urologia Internationalis. 55(4). 209–214. 1 indexed citations

18.

Yagisawa, Takashi, et al.. (1995). Successful Renal Autotrans-plantation with Y-Prosthetic Aortic Replacement in a Patient with Complete Occlusion of Abdominal Aorta and Renal Artery. Urologia Internationalis. 55(1). 46–50. 3 indexed citations

19.

Nakada, Teruhiro, Yōko Kubota, Isoji Sasagawa, et al.. (1995). Therapeutic Outcome of Primary Aldosteronism: Adrenalectomy Versus Enucleation of Aldosterone-Producing Adenoma. The Journal of Urology. 153(6). 1775–1780. 89 indexed citations

20.

Nakada, Teruhiro, Yōko Kubota, Isoji Sasagawa, et al.. (1995). Remarkably Suppressed Manganese Superoxide Dismutase Activity in Malignant Pheochromocytoma. The Journal of Urology. 153(6). 1787–1790. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact